Biocon Q3FY23 Revenue at Rs 3,020 Cr, Up 36%; Biosimilars Up …

Biocon Q3FY23 Revenue At Rs 3,020 Cr, Up 36%; Biosimilars Up …

2 weeks from now

Feb 14, 2023  · Biocon Q3FY23 Revenue at Rs 3,020 Cr, Up 36%; Biosimilars Up 54%; Research Services Up 23%; Generics Up 18%. CONTACT +91 80 2808 2808 . [email protected] . About …

biocon.com

Biocon Q3FY23 Revenue At Rs 3,020 Cr, Up 36%, Biosimilars Up …

2 weeks from now

Feb 15, 2023  · Biocon Q3FY23 Revenue at Rs 3,020 Cr, Up 36%, Biosimilars Up 54%, Research Services Up 23%, Generics Up 18% February 15, 2023 at 07:48 am EST ... Up 36%, …

marketscreener.com

Biocon’s Q3 FY23 Revenue Stands At Rs 3,020 Crore, Up By 36%

2 weeks from now

Feb 15, 2023  · Net profit for the quarter, excluding an exceptional item, stood at Rs 140 crore. “Biocon’s consolidated revenues for the quarter grew 36% to Rs 3,020 crore on the back of …

biovoicenews.com

Biocon Q3FY23 Revenue At Rs 3,020 Crore, Up 36% - Investing.com …

2 weeks from now

Bengaluru, Feb 14 (IANS) Global biopharmaceuticals company Biocon (NS: BION) Ltd on Tuesday announced its net revenue from operations for the quarter, ending December 31, …

investing.com

Biocon Q3FY23 Revenue At Rs 3,020 Cr, Up 36%, Biosimilars Up …

2 weeks from now

Feb 15, 2023  · Bengaluru - Biocon Ltd , an innovation-led global biopharmaceuticals company, today announced its consolidated financial results for the third quarter ended December 31, …

marketscreener.com

Biocon Q3FY23 Revenue At Rs 3,020 Crore, Up 36%

2 weeks from now

Feb 14, 2023  · Biocon Q3FY23 revenue at Rs 3,020 crore, up 36% - Bengaluru, Feb 14 Global biopharmaceuticals company Biocon Ltd on Tuesday announced its net revenue from …

lokmattimes.com

Biocon Q3FY23 Revenue At Rs 3,020 Crore, Up 36%

2 weeks from now

Feb 15, 2023  · Biocon Q3FY23 revenue at Rs 3,020 crore, up 36%. ... 2022. increased by 36 per cent to Rs 3,020 crore from Rs 2,223 crore in the same period last year. ... of the global …

webindia123.com

Biocon Q3 Net Profit Falls 25 Per Cent; Revenue Up 36 Per Cent At Rs ...

2 weeks from now

Feb 15, 2023  · Biocon Q3 net profit falls 25 per cent; revenue up 36 per cent at Rs 3,020 crore. The company's net R&D investments for the quarter grew by 144% to Rs 337 crore, …

newindianexpress.com

Biocon Q3 FY23 Revenue Up 36% - Indianpharmapost.com

2 weeks from now

Feb 17, 2023  · Biocon Ltd., an innovation-led global biopharmaceuticals company. has announced Q3 FY23 revenue at Rs.3,020 crore, up 36%. “Q3 FY23 has been an eventful …

indianpharmapost.com

Biocon Q3FY23 Revenue At Rs 3,020 Crore, Up 36% - Newkerala.com

2 weeks from now

Feb 15, 2023  · Bengaluru, Feb 14: Global biopharmaceuticals company Biocon Ltd on Tuesday announced its net revenue from operations for the quarter, ending December 31, 2022. …

newkerala.com

Biocon Q3FY23 Revenue At Rs 3,020 Crore, Up 36% - Magazinestime

2 weeks from now

Feb 15, 2023  · Bengaluru, Feb 14 (IANS) Global biopharmaceuticals company Biocon Ltd on Tuesday announced its net revenue from operations for the quarter, ending December 31, …

magazinestime.com

Biocon Q3FY23 Earnings: Revenue Up 36%, PAT Falls 25% YoY

2 weeks from now

Feb 14, 2023  · Biocon Q3FY23 Earnings: Revenue up 36%, PAT falls 25% YoY. With a market capitalization of ₹ 28,202.09 Cr, Biocon Ltd. is a large-cap company that engages in the …

livemint.com

Biocon Reports Net Loss Of Rs 42 Cr, Sales Up By 36% YoY In …

2 weeks from now

Feb 14, 2023  · The company's generics grew by 18 per cent year on year to Rs 718 crores, while its biosimilar business stood at Rs 1,507 crores in the December quarter, up by 54 per cent …

businessworld.in

Biocon Q3FY23 Revenue At Rs 3,020 Crore, Up 36% - Daijiworld

2 weeks from now

Feb 14, 2023  · Biocon Q3FY23 revenue at Rs 3,020 crore, up 36% Tue, Feb 14 2023 10:49:02 PM Bengaluru, Feb 14 (IANS): Global biopharmaceuticals company Biocon Ltd on Tuesday …

daijiworld.com

Net Profit (excluding Exceptional Items) At Rs 140 Cr - Biocon

2 weeks from now

6 BIOSIMILARS: Biocon Biologics Limited (BBL) • Q3FY23 revenue at Rs 1,507 Crore, up 54% (YoY) from Rs 981 Crore in Q3FY22. • Served ~5.4 million patients (MAT Dec 2022 basis)## …

biocon.com

Biocon Q3FY23 Revenue At Rs 3,020 Crore, Up 36%

2 weeks from now

Biocon Q3FY23 revenue at Rs 3,020 crore, up 36% ... 2022. increased by 36 per cent to Rs 3,020 crore from Rs 2,223 crore in the same period ... the financials will recognise the entire …

suryaa.com

Biocon Q3FY25 Revenue At Rs 3,856 Cr, Up 7%

2 weeks from now

Jan 30, 2025  · Financial Commentary: Q3FY25. Consolidated Total Revenue for Q3FY25 was at Rs 3,856 crore.Reported 7% YoY growth on a like-for-like basis, after adjusting for Branded …

biocon.com

Biocon Buys Back An Investor Stake In Biologics Unit, Posts Rs 25 …

2 weeks from now

Jan 30, 2025  · Biocon's board has approved the acquisition of 1.5% equity in Biocon Biologics for Rs 550 crore, increasing its stake to 90.2%. The deal is expected to complete by February 1, …

indiatimes.com